Probi AB (Symrise)
EMEA
Lund
,
Sweden
Established
FOUNDED
1991
HEADCOUNT
101-500
FUNDING
Subsidiary
Keywords:
fermentation, probiotics, bacteria, nutraceuticals, microbiome, therapeutics
BUSINESS
Probi is a B2B probiotics ingredient supplier serving dietary supplements and functional food customers globally. The German flavors and fragrances multinational Symrise AG acquired Probi in January 2025. Reported sales were approximately USD 60 million in 2023 with approximately 150-200 employees and more than 400 patents globally.
BIOTECH INVOLVEMENT
The technology is centered on Lactobacillus and Bifidobacterium strains (notably L. plantarum 299V/LP299V, with more than 70 clinical trials and 300+ peer-reviewed publications). Capabilities cover strain selection, clinical documentation, fermentation, downstream processing of live bacteria, freeze-drying, and stable formulation in capsules, tablets, powders, and food matrices, with therapeutic positioning spanning digestive, immune, metabolic, women's, oral, and active nutrition health areas.
TECHNOLOGY PLATFORM
probiotic strain development; fermentation
PRIMARY PRODUCTS
Probiotic strains (e.g. LP299V); synbiotic solutions; BLIS strains for oral health